Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
0.2140
-0.0040 (-1.83%)
At close: Nov 13, 2026, 4:00 PM EST
0.2037
-0.0103 (-4.81%)
After-hours: Nov 13, 2026, 7:33 PM EST

Acumen Pharmaceuticals Statistics

Total Valuation

ABOS has a market cap or net worth of $15.48 million. The enterprise value is -$36.81 million.

Market Cap15.48M
Enterprise Value -36.81M

Important Dates

The last earnings date was Monday, October 26, 2026, before market open.

Earnings Date Oct 26, 2026
Ex-Dividend Date n/a

Share Statistics

ABOS has 72.33 million shares outstanding. The number of shares has increased by 11.05% in one year.

Current Share Class 72.33M
Shares Outstanding 72.33M
Shares Change (YoY) +11.05%
Shares Change (QoQ) +0.10%
Owned by Insiders (%) 14.60%
Owned by Institutions (%) 35.88%
Float 37.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.45
P/TBV Ratio 0.45
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.76.

Current Ratio 1.89
Quick Ratio 1.79
Debt / Equity 0.76
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -24.65

Financial Efficiency

Return on equity (ROE) is -162.72% and return on invested capital (ROIC) is -70.78%.

Return on Equity (ROE) -162.72%
Return on Assets (ROA) -57.46%
Return on Invested Capital (ROIC) -70.78%
Return on Capital Employed (ROCE) -258.70%
Weighted Average Cost of Capital (WACC) 10.52%
Revenue Per Employee n/a
Profits Per Employee -$1.70M
Employee Count61
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -89.03% in the last 52 weeks. The beta is 0.45, so ABOS's price volatility has been lower than the market average.

Beta (5Y) 0.45
52-Week Price Change -89.03%
50-Day Moving Average 1.85
200-Day Moving Average 2.40
Relative Strength Index (RSI) 21.42
Average Volume (20 Days) 7,127,737

Short Selling Information

The latest short interest is 4.56 million, so 6.30% of the outstanding shares have been sold short.

Short Interest 4.56M
Short Previous Month 3.09M
Short % of Shares Out 6.30%
Short % of Float 12.30%
Short Ratio (days to cover) 1.24

Income Statement

Revenue n/a
Gross Profit -85.93M
Operating Income -104.72M
Pretax Income -103.96M
Net Income -103.96M
EBITDA -104.67M
EBIT -104.72M
Earnings Per Share (EPS) -$1.55
Full Income Statement

Balance Sheet

The company has $78.60 million in cash and $26.31 million in debt, with a net cash position of $52.29 million or $0.72 per share.

Cash & Cash Equivalents 78.60M
Total Debt 26.31M
Net Cash 52.29M
Net Cash Per Share $0.72
Equity (Book Value) 34.61M
Book Value Per Share 0.48
Working Capital 40.05M
Full Balance Sheet

Cash Flow

Operating Cash Flow -87.95M
Capital Expenditures n/a
Depreciation & Amortization 47,000
Net Borrowing -4.99M
Free Cash Flow -87.95M
FCF Per Share -$1.22
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ABOS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -11.05%
Shareholder Yield -11.05%
Earnings Yield -723.82%
FCF Yield -568.24%

Analyst Forecast

The average price target for ABOS is $1.00, which is 367.29% higher than the current price. The consensus rating is "Hold".

Price Target $1.00
Price Target Difference 367.29%
Analyst Consensus Hold
Analyst Count 6
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2